Predictors of distress and quality of life in patients undergoing cancer therapy: Impact of treatment type and decisional role

Psycho-Oncology

Volumn 19, Issue 6, 2010, Pages 606-616

  Hack, Thomas F ^a,b   Pickles, Tom ^c,d   Ruether, J Dean ^e,f   Weir, Lorna ^c,d   Bultz, Barry D ^e,f   Mackey, John ^g,h   Degner, Lesley F ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CANCERCARE MANITOBA   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e TOM BAKER CANCER CENTRE   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g CROSS CANCER INSTITUTE   (Canada)

^h UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adjustment; Breast cancer; Cancer; Oncology; Patient physician; Prostate cancer; Psychosocial; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; AUDIO RECORDING; BREAST CANCER; CANADA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER THERAPY; CONSULTATION; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; FEMALE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTIVARIATE ANALYSIS OF COVARIANCE; PREDICTION; PROSTATE CANCER; QUALITY OF LIFE; RISK FACTOR; SOCIAL PSYCHOLOGY;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DEPRESSION; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT PARTICIPATION; PROSTATIC NEOPLASMS; QUALITY OF LIFE; REGRESSION ANALYSIS; STRESS, PSYCHOLOGICAL; TAPE RECORDING; TREATMENT OUTCOME;

EID: 77953259749     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1590     Document Type: Article

References (41)

1. Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol 2005;23:6613-6622.
2. Jacobsen PB, Stein K. Is fatigue a long-term side effect of breast cancer treatment? Cancer Control 1999;6:256-263.
3. de Jong N, Candel MJJM, Schouten HC, Abu-Saad HH, Courtens AM. Course of the fatigue dimension activity level and the interference of fatigue with daily living activities for patients with breast cancer receiving adjuvant chemotherapy. Cancer Nurs 2006;29(5):E1-E13.
4. Meyers CA. Neurocognitive dysfunction in cancer patients. Oncology 2000;14:75-79.
5. Olin JJ. Cognitive function after systemic therapy for breast cancer. Oncology 2001;15:613-618. (Pubitemid 33739126)
6. Schagen SB, Muller MJ, Boogerd W, van Dam FSAM. Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective. Clin Br Cancer 2002;3(Suppl 3):S100-S108.
7. Coster S, Fallowfield LJ. The impact of endocrine therapy on patients with breast cancer: a review of the literature. Breast 2002;11:1-12.
8. Fallowfield LJ. Evolution of breast cancer treatments: current options and quality-of-life considerations. Eur J Oncol Nurse 2004;8(Suppl 2):S75-S82.
9. Hollenbeck BK, Dunn RL, Wei JT, Sandler HM, Sanda MG. Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer. Urol Rep 2004;5:212-219.
10. Bacon CG, Giovannucci E, Testa M, Glass TA, Kawachi I. The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer 2002;94:862-871.
11. O'Connor KM, Fitzpatrick JM. Side-effects of treatments for locally advanced prostate cancer. BJU Int 2006;97:22-28.
12. Penson DF, Litwin MS. Quality of life after treatment for prostate cancer. Curr Urol Rep 2003;4:185-195.
13. Pickles T. What's a man to do? Treatment options for localized prostate cancer. Can Fam Physician 2004;50:65-72. (Pubitemid 38111330)
14. Folkman S. Positive psychological states and coping with severe stress. Soc Sci Med 1997;45:1207-1221.
15. Stanton AL, Danoff-Burg S, Huggins ME. The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psycho-Oncol 2002;11:93-102.
16. Hack TF, Degner LF, Watson P, Sinha L. Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer. Psycho-Oncol 2006;15:9-19.
17. Gattellari M, Butow PN, Tattersall MHN. Sharing decisions in cancer care. Soc Sci Med 2001;52:1865-1878.
18. Hack TF, Pickles T, Bultz BD, Ruether JD, Weir LM, Degner LF et al. Impact of providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: a multi-site, randomized, controlled trial. J Clin Oncol 2003;21:4138-4144.
19. Hack TF, Pickles T, Bultz BD, Ruether JD, Degner LF. Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi-site, randomized, controlled trial. Psycho-Oncol 2007;16:543-552.
20. Degner LF, Kristjanson LJ, Bowman D, Sloan JA, Carriere KC, O'Neil J et al. Information needs and decisional preferences in women with breast cancer. JAMA 1997;277:1485-1492. (Pubitemid 27208893)
21. Degner LF, Russell CA. Preferences for treatment control in adults with cancer. Res Nurs Health 1988;11:367-374.
22. Degner LF, Sloan JA. Decision-making during serious illness: what role do patients really want to play? J Clin Epidemiol 1992;45:941-950.
23. McNair DM, Lorr M, Droppleman LF. Manual for the Profile of Mood States. Educational and Industrial Testing Service: San Diego, CA, 1971.
24. Cella D. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System (Version 4). Evanston Northwestern Healthcare and Northwestern University, Evanston, IL, 1997.
25. Reddon JR, Marceau R, Holden RR. A confirmatory evaluation of the profile of mood states: convergent and discriminant item validity. J Psychopathol Behav Assess 1985;7:243-259. (Pubitemid 16106167)
26. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR et al. Reliability and validity of the functional assessment of cancer therapy - breast quality-of-life instrument. J Clin Oncol 1997;15:974-986. (Pubitemid 27106280)
27. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-579.
28. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy - prostate instrument. Urology 1997;50:920-928.
29. Hummel TJ, Sligo J. An empirical comparison of univariate and multivariate analysis of variance procedures. Psychol Bull 1971;76:49-57.
30. Street Jr RL, Gordon HS, Ward MM, Krupat E, Kravitz RL. Patient participation in medical consultations: why some patients are more involved than others. Med Care 2005;43:960-969.
31. Jacobsen PB, Donovan KA, Trask PC, Felishman SB, Zabora J, Baker F, Holland JC. Screening for psychologic distress in ambulatory cancer patients. Cancer 2005;103:1494-1502.
32. Land SR, Kopec JA, Yothers G, Anderson S, Day R, Tang G, Ganz PA, Fisher B, Wolmark N. Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23. Breast Cancer Res Treat 2004;86:153-164.
33. Peppercorn J, Herndon II J, Kornblith AB, Peters W, Ahles T, Vredenburgh J, Schwartz G, Shpall E, Hurd DD, Holland J, Winer E. For the cancer and leukemia group B (CALGB) and the southwestern oncology group (SWOG). Quality of life among patients with stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy. Cancer 2005;104:1580-1589.
34. Fallowfield L, Bliss JM, Porter LS, Price MH, Snowdon CF, Jones SE, Coombes RC, Hall E. Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. J Clin Oncol 2006;24:910-917. (Pubitemid 46638844)
35. Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A. Quality of life of postmenopausal women in the arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial. J Clin Oncol 2004;22:4261-4271.
36. Gaston CM, Mitchell G. Information giving and decision-making in patients with advanced cancer: a systematic review. Soc Sci Med 2005;61:2252-2264.
37. Scott JT, Karmsen M, Prictor MJ, Entwistle VA, Sowden AJ, Watt I. Recording or summaries of consultations for people with cancer. The Cochrane Library, Issue 2, 2007. Wiley.
38. Bultz BD, Carlson L. Emotional distress: the sixth vital sign in cancer care. J Clin Oncol 2005;10:6440-6441.
39. Carver C. Enhancing adaptation during treatment and the role of individual differences. Cancer 2005;104(11 suppl):2602-2607.
40. Steinberg ML, Fremont A, Khan DC, Huang D, Knapp H, Karaman D, Forge N, Andre K, Chaiken LM, Streeter OE. Lay patient navigator program imple mentation for equal access to cancer care and clinical trials: essential steps and initial challenges. Cancer 2006;107:2669-2677.
41. Vodermaier A, Caspari C, Koehm J, Kahlert S, Ditsch N, Untch M. Contextual factors in shared decision making: a randomized controlled trial in women with strong suspicion of breast cancer. Br J Cancer 2009;100:590-597.